Related Experiment Video

Updated: Mar 30, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

16.9K

Microglial toll-like receptors and Alzheimer's disease

Fan Su1, Feng Bai1, Hong Zhou1

  • 1Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.

Brain, Behavior, and Immunity
|November 4, 2015
PubMed

Insights

Microglial toll-like receptors (TLRs) play a dual role in Alzheimer's disease (AD) pathology. Research shows TLRs are involved in AD, with genetic links suggesting their impact on disease risk.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Microglial activation is a key feature of Alzheimer's disease (AD).
  • Microglial toll-like receptors (TLRs) are increasingly recognized for their role in AD pathogenesis.
  • TLRs can have both protective and harmful effects in AD-related conditions.

Purpose of the Study:

  • To review the current evidence linking toll-like receptors (TLRs) to Alzheimer's disease (AD).
  • To summarize the known beneficial and detrimental roles of TLRs in AD pathology.

Main Methods:

  • Review of existing scientific literature.
  • Analysis of data from transgenic animal models of AD.
  • Examination of genetic polymorphism studies related to TLRs and AD risk.

Main Results:

  • Transgenic animal models provide evidence for TLRs' association with AD.
  • Genetic polymorphism analyses suggest TLRs influence AD risk.
  • TLRs exhibit complex, dual roles in AD pathogenesis.

Conclusions:

  • Toll-like receptors (TLRs) are significantly implicated in Alzheimer's disease.
  • Further research is needed to elucidate the specific mechanisms of TLRs in AD.
Keywords:
Alzheimer’s diseaseMicrogliaNeuroinflammationToll-like receptors

More Related Videos

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.6K
Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

35.7K

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
88.9K